Gravar-mail: NIMG-72. PROGNOSTIC VALUE OF [(18)F]-FDG POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH RECURRENT GLIOBLASTOMA RECEIVING BEVACIZUMAB